By Fatma Younis
CVS Health, the largest U.S. healthcare conglomerate valued at $117 billion, announced plans to separate its retail pharmacy operations from its insurance and benefits businesses. The move ends an era of consolidation that saw healthcare companies grow into massive integrated entities.
Regulatory Pressure Drives Restructuring
The company faces mounting pressure from lawmakers and regulators who argue that CVS Health, UnitedHealth Group, and Cigna — which together control roughly 80% of the market — have become too dominant, leading to higher medical costs. CVS Health generated over $400 billion in revenue last year.
New Corporate Structure
Under the plan, CVS Health will spin off its 9,000 pharmacies, in-store clinics, and mail-order prescription business into a new entity named CVS Pharmacy. A second company will retain the CVS Health name and house the insurer Aetna, the pharmacy benefits manager Caremark, and other businesses providing home visits and primary care for older adults.
Political and Legal Context
Arkansas and Tennessee have passed laws restricting companies from managing prescription benefits while also operating retail and mail-order pharmacies. At the federal level, Senators Josh Hawley and Elizabeth Warren have introduced antitrust legislation aimed at breaking up such integrated healthcare giants.
CEO Comments and Timeline
David Joyner, CVS's chief executive and chair, will lead the healthcare solutions business. He described the split as a proactive evolution to deliver greater affordability, access, and simplicity. The breakup is planned for early 2028.
